2026 Nobel medicine prize honours the pioneers of optogenetics

The brief in 4 cards

1. Context1 / 4
   • The Nobel Assembly at Karolinska Institutet awarded the 2026 Nobel Prize in Physiology or Medicine jointly to Karl Deisseroth (Stanford University, United States), Peter Hegemann (Humboldt University of Berlin, Germany) and Georg Nagel (University of Würzburg, Germany).
   • The citation is "for their discoveries concerning light-gated ion channels and optogenetics".
   • Hegemann and Nagel discovered channelrhodopsin, a light-sensitive protein in a single-celled green alga, Chlamydomonas. Deisseroth turned it into a light-controlled switch for nerve cells, and showed it working in the brains of living mice.
   • The Assembly said the work allowed neuroscience to move beyond observing correlations, to testing how particular neurons and circuits relate to behaviour and emotion.
2. Note2 / 4

   What is optogenetics?

   The table below sets out how the technique works, step by step.

   Step	What happens
   1. Choose the target cells	Researchers select one specific type of nerve cell
   2. Deliver the gene	The gene for a light-sensitive protein, such as channelrhodopsin, is put into only those cells, usually using a harmless virus
   3. The cells make the protein	The protein sits in the cell membrane as a light-gated ion channel
   4. Shine light	Light opens the channel, ions flow in and the neuron fires; other proteins can silence neurons instead
   5. Watch the effect	Researchers observe the change in behaviour, memory or emotion

   • Why it matters. Drugs act on many cell types, and act slowly. Electrodes stimulate whatever lies nearby. Optogenetics reaches defined cell types with millisecond precision.
   • From correlation to causation. Earlier methods could show that certain neurons were active during a behaviour. Optogenetics lets scientists switch those neurons on or off, to test whether they cause it.
3. Key concepts3 / 4

   1. What is an ion channel?

   A protein pore in a cell membrane that opens to let charged particles, or ions, pass through. Nerve signals depend on ions moving across the membrane. A light-gated channel opens in response to light, much as a light-sensitive switch turns on a lamp only when it detects light.

   2. What is channelrhodopsin?

   A protein the alga uses to sense light and swim towards it. Hegemann and Nagel showed that it is itself an ion channel, one that opens when struck by light, which is what made it usable in other cells.

   3. How is the gene delivered?

   Usually by a modified, harmless virus such as an adeno-associated virus (AAV), which carries the gene into the target cells. The same delivery approach is used in gene therapy.

   4. How far has it reached medicine?

   Mostly as a research tool, used in animals to study circuits linked to Parkinson's disease, depression, addiction and other conditions. In humans, the clearest result so far is a 2021 report of partial vision restoration in one patient with retinitis pigmentosa, who could locate and touch objects using special light-projecting goggles after optogenetic gene therapy. Larger trials are under way.

4. Note4 / 4

   Significance and limits

   • For science. It has become one of the most widely used tools in modern neuroscience, making it possible to map which circuits drive memory, fear, reward and movement.
   • For medicine. It points towards treatments aimed at faulty circuits rather than whole brain regions, and towards gene therapy for some forms of blindness that does not depend on which gene is mutated.
   • The limits. Using it in the human brain would mean introducing foreign genes and delivering light deep into tissue. Georg Nagel himself remarked that he knew of only one patient so far who had benefited.

Swipe or use ← → to move between cards.